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 Incomplete X-linked congenital stationary night blind-
ness (CSNB2) is a recessive, nonprogressive visual disease in
humans. CSNB2 was originally described as a distinct form
of night blindness characterized by an extremely reduced
(negative type) electroretinogram (ERG) b wave due to im-
paired transduction of the photoreceptor response to second
order neurons of the retina [1]. Mutations in the human
CACNA1F gene encoding the pore-forming Cav1.4 (α1F)
subunit of voltage gated L-type calcium channels have been
firmly linked to CSNB2 and are thought to be the underlying
molecular lesion causing CSNB2 [2,3]. The immunohis-
tochemical localization of this subunit to putative active zones
of the terminals of rod photoreceptors [4,5] of the rat retina
supports this notion. The recently reported histological and
ERG abnormalities observed in transgenic mice in which the
cacna1f gene is disrupted [6] and in the naturally occurring
cacna1f mutant mouse, nob2 [7], add further support for this
hypothesis.
In a recent communication, Morgans et al. [8] suggested
that the residual photoreceptor function observed in nob2 mice
and humans with CSNB2 may be the result of rod signals trans-
ferred to cones through rod-cone coupling and subsequent
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Purpose: Mutations in the CACNA1F gene encoding the L-type calcium channel pore-forming Cav1.4 (α1F) subunit in
humans result in an incomplete form of congenital stationary night blindness (CSNB2) with residual photoreceptor func-
tion. It has been postulated that this residual function, at least in part, may be mediated by another L-type calcium channel
subunit, Cav1.3 (α1D), expressed within cone photoreceptors. However, the expression of the calcium channel Cav1.3
(α1D) subunit within photoreceptors remains debatable due to discrepancies among the immunohistochemical studies
reported in the literature. In order to get around the innate complications of utilizing unproven antibodies and to shed light
on this discussion, we investigated the mRNA expression profile for the Cav1.3 (α1D) subunit in the mouse retina.
Methods: In situ hybridization was performed on wild type mouse retinal sections with two independent sets of digoxigenin-
11-UTP-labeled Cav1.3 (α1D)-specific sense and antisense cRNA probes. The two probe sets employed correspond to
two distinct regions of the Cav1.3 (α1D) subunit mRNA, each encoding a different fragment of the Cav1.3 (α1D) polypep-
tide. In situ hybridization of wild type mouse brain sections with these same probes was performed as an additional
control for specificity.
Results: Abundant L-type calcium channel Cav1.3 (α1D) subunit mRNA expression was confirmed in most cells of the
outer nuclear layer using two independent Cav1.3 (α1D)-specific antisense cRNA probes, confirming expression in rod
photoreceptors. Cav1.3 (α1D) mRNA expression was also observed within most cells of the inner nuclear layer and
ganglion cell layers using these same antisense cRNA probes. No labeling of tissue was observed using either sense cRNA
probe. In situ detection of concentrated Cav1.3 (α1D) mRNA expression within the hippocampus and Purkinje and gran-
ule cells of the cerebellum of wild type mouse brain with these same probes confirmed specificity of the probes.
Conclusions: Our finding of expression of the L-type calcium channel Cav1.3 (α1D) subunit mRNA in rods substantiates
the possibility that this pore-forming subunit may be a competent component of channels mediating the residual photore-
ceptor responses observed in mutant mice lacking functional Cav1.4 (α1F) subunits and in humans with CSNB2. Further-
more, the combined observations of abundant expression of Cav1.3 (α1D) mRNA in wild type rods and the large reduction
in the transmission of photoreceptor responses in mice lacking Cav1.4 (α1F) raises the possibility that Cav1.3 (α1D)
protein expression levels, localization, or functioning might be concomitantly altered by disruption of the Cav1.4 (α1F)
subunit in rods. To date, no studies of Cav1.3 (α1D) mRNA nor protein expression levels or localization in cacna1f mutant
mice or humans with CSNB2 have been published. Our findings warrant such studies to address the abovementioned
possibilities. Finally, the observation of Cav1.3 (α1D) mRNA expression in multiple retinal cell types suggests the poten-
tial for a broader role for this L-type calcium channel subunit in overall functioning of the normal retina than previously
appreciated. We therefore suggest that lesions in either the gene encoding the L-type calcium channel Cav1.3 (α1D)
subunit or other molecules that interact with and regulate it may underlie one or more retinopathies with currently uniden-
tified molecular etiologies.
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764forwarding via neurotransmitter release from the cone syn-
apse controlled by another L-type calcium channel subunit
isoform, such as Cav1.3 (α1D). In this same report, Morgans
et al. demonstrate Cav1.3 (α1D) immunoreactivity in wild type
mouse cone pedicles, consistent with previously reported im-
munohistochemical localization of Cav1.3 (α1D) to cone ter-
minals within tree shrew retina [9,10]. In this same communi-
cation [8], however, Morgans et al. acknowledge a second and
more parsimonious explanation: the presence of another cal-
cium channel α1 subunit isomer within rod photoreceptors
that may mediate neurotransmitter release from the terminals
of rods.
Although Morgans’ immunohistochemical data support
the expression of Cav1.3 (α1D) in mouse cones and not rods,
Xu et al., using a different anti-Cav1.3 (α1D) antibody, re-
ported intense immunohistochemical labeling of rod somata
in the rat retina [11]. There are 2 potential explanations for the
discrepancy in these reports regarding the localization of Cav1.3
(α1D) within photoreceptors. As Morgans et al. [8] examined
mouse retina and Xu et al. [11] examined rat retina, the differ-
ence may simply reflect a species variation in calcium chan-
nel subunit expression. This difference in results could also
be the consequence of using different antibodies. As the anti-
bodies used in the two studies were generated against distinct
regions of the Cav1.3 (α1D) subunit, they may actually detect
different Cav1.3 (α1D) polypeptides translated from different
mRNA spice variants of the Cav1.3 (α1D) gene. Such reliance
upon antibodies, the specificity of which has not been rigor-
ously demonstrated using tissues from mice with a targeted
deletion of the cacna1d gene encoding the Cav1.3 (α1D) sub-
unit, is a limitation of both studies. For this reason, we de-
cided to investigate the mRNA expression profile of Cav1.3
(α1D) within the mouse retina using in situ hybridization, with
the goal of enlightening the discussion of its potential contri-
bution to forwarding of light signals from rod photoreceptors
to second order neurons within the retina. Portions of this study
have been previously reported in abstract form (Steele, EC Jr.
Analysis of L-type calcium channel Cav1.3 subunit expres-
sion in the mouse retina. Invest Ophthalmol Vis Sci 2006; 47:E-
Abstract 1046).
METHODS
Animals:  Wild type C57Bl/6J mice were obtained from Jack-
son Lab for these studies. All animal procedures conformed
to the humane treatment of animals as prescribed by the Insti-
tute for Laboratory Animal Research (Guide for the Care and
Use of Laboratory Animals) and by the Association for Re-
search in Vision and Ophthalmology (ARVO) and were ap-
proved by the Morehouse School of Medicine Institutional
Animal Care and Use Committee.
In situ hybridization of retinal and brain sections:  Eyes
and brains were immediately dissected from animals follow-
ing euthanasia. Corneas and lenses were immediately dissected
from freshly enucleated eyes. Eyecups were then fixed by
immersion in 1X phosphate buffered saline (PBS) containing
4% paraformaldehde and diethylpyrocarbonate (DEPC) for
15 min at room temperature. Brains were transected along the
midline and fixed by immersion in the same fixative over-
night at 4 °C. Eyecups and brains were then rinsed 3 times for
5 min each at room temperature with 1X PBS containing DEPC
before they were cryoprotected in 1X PBS containing 30%
sucrose and DEPC at 4 °C overnight.
Cryprotected eyes and brains were mounted in Neg50 (Ri-
chard Allen Scientific) and flash frozen in liquid nitrogen. A
Microm HM 550 OMVP cryostat was then used to cut 14 µm
sections, which were subsequently mounted onto Superfrost
Plus coated slides (Fisher Scientific).
Total RNA was isolated from 2 wild type C57BL/6J reti-
nae using Trizol Reagent (Invitrogen) according to the
manufacturer’s specifications and mixed. Two independent
fragments of the L-type calcium channel Cav1.3 (α1D) sub-
unit RNA were amplified from total murine retinal RNA us-
ing Cav1.3 (α1D)-specific oligos in conjunction with the One-
Step RT-PCR amplification kit (Invitrogen). Probe A corre-
sponded to nucleotides 189-715 of GenBank accession num-
ber NM_028981 and was amplified using the following oligos:
sense, 5'-AGG CAA ACT ATG CAA GAG GCA CCA G-3'
and antisense, 5'-ATT CCA TCC ATT CCT AAC GTA AGC-
3'.
Probe B corresponded to nucleotides 2486-2742 of
GenBank accession number NM_028981 and was amplified
using the following oligos: sense, 5'-AAC AAA CCA GAA
GTC AAC CAG ATA GCC-3' and antisense, 5'-GGG TTG
GTC TTG CTA AGA ATG AAG-3'. These fragments were
subcloned into the pCRII-TOPO vector using the TOPO TA
Cloning Kit Dual Promoter (Invitrogen) and sequenced to
confirm identity. These constructs were then linearized and
used to generate antisense and sense probes with the SP6/T7
DIG RNA Labeling kit (Roche) and digoxigenin-11-UTP
(Roche) according to the manufacturer’s specifications. Probe
labeling efficiency was assayed according to the
manufacturer’s specifications by preparing serial dilutions and
spotting onto a nitrocellulose membrane and detecting with
alkaline phosphatase-conjugated anti-DIG antibody. The re-
sulting intensities were then used according to the labeling kit
manufacturer’s specifications to estimate labeled probe con-
centrations.
Slides with freshly cut sections were air dried for 30 min
at room temperature and then prehybridized for 2 h at room
temperature in a humidified chamber with hybridization buffer
composed as follows: 50% formamide (Sigma-Aldrich), 5X
SSC, 5X Denhardt’s solution (Invitrogen), 250 µg/ml MRE
600 tRNA (Roche), DEPC-treated water. Hybridization buffer
containing about 500 ng /ml DIG-11-UTP-labeled RNA probe,
which was preheated to 80 °C for 5 min and then placed on
ice, was added to sections before covering with DEPC-treated
coverslips and incubating overnight at 61 °C (Probe A) or 58
°C (Probe B) in a humidified chamber. For each probe pair, a
range of hybridization temperatures 55 °C, 58 °C, and 61 °C
was tested to empirically determine the hybridization tempera-
ture which yielded strong staining of tissues with antisense
probe following a short colorometric detection reaction time
but no staining with sense probe following the same
colorometric detection reaction time.
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765Following hybridization, slides were washed in 0.2X SSC
2 times for 30 min 1 h at 68 °C to remove unbound probe.
Slides were then treated with RNase (10 mg/ml) in 0.5M NaCl,
10 mM Tris pH7.5, 5 mM EDTA for 30 min at 37 °C. After
RNase treatment, slides were rinsed with 0.2X SSC for 5 min
at room temperature, followed by a rinse in 0.1 M Tris pH7.5,
0.15 NaCl for 5 min at room temperature. Slides were then
blocked in 0.1 M Tris pH7.5, 0.15 NaCl containing 1-10%
heat inactivated normal goat serum for 1 h at room tempera-
ture. Slides were then incubated in this same blocking buffer
containing alkaline phosphatase-conjugated anti-DIG antibody
(diluted 1:400) for 2 h at room temperature. Following incu-
bation with antibody, slides were rinsed 3 times for 7 min with
blocking buffer at room temperature to remove unbound anti-
body. Slides were then equilibrated with a buffer containing
0.1 M Tris pH 9.5, 0.1 M NaCl, 50 mM MgCl2 for 5 min at
room temperature, before staining with BCIP/NBT in the dark
(Vector Labs) according to the manufacturer’s recommenda-
tions. The colorometric development reaction was stopped by
rinsing with TE Buffer (10 mM Tris, 1 mM EDTA, pH 8.0),
then with water.
Stained slides were mounted with Vectashield mounting
medium (Vector Labs) and images were acquired using a Zeiss
Axioskop 2 plus overhead microscope equipped with a Zeiss
Axiocam HRc CCD camera with AxioVision acquisition and
analysis software. Microsoft Powerpoint and Adobe Photoshop
were subsequently employed to assemble images into final
figure format.
RESULTS
In situ hybridization of murine retinal sections confirms ex-
pression of L-type calcium channel Cav1.3 (α1D) subunit in
rod photoreceptors of the outer nuclear layer as well as the
inner nuclear and ganglion cell layers:  We utilized two inde-
pendent sets of Cav1.3 (α1D)-specific cRNA probes, corre-
sponding to mRNA encoding 2 distinct regions of the L-type
calcium channel Cav1.3 (α1D) subunit, in our in situ hybrid-
ization analyses of wild type murine retinal sections. One set
of sense and antisense probes, designated as Probe A in Fig-
ure 1, corresponds to a 5' fragment of the mRNA encoding an
N-terminal fragment of the Cav1.3 (α1D) subunit. The second
set of sense and antisense probes, designated as Probe B in
Figure 1, corresponds to an internal fragment of the mRNA
encoding a fragment of the intracellular loop between the re-
peat domains II and III of the polypeptide. Probe B encom-
passes the peptide used as antigen to generate the commer-
cially available anti-Cav1.3 (α1D) antibody employed in many
of the previously published immunohistochemical studies of
retina, making our mRNA results directly comparable to these
studies. Both sets of these probe sequences were blasted against
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Figure 1. Topological correspondence of Cav1.3 (α1D) in situ hybridization probes.  Voltage-dependent calcium channel pore-forming α1
subunits are composed of a single polypeptide consisting of 4 repeating domains (I-IV) joined by intracellular loops. Each repeat domain
consists of 6 transmembrane-spanning regions (1-6) connected by intracellular and extracellular loops. Antisense and sense probe sets were
generated using cRNA corresponding to 2 different topological regions of the Cav1.3 (α1D) subunit polypeptide. Probe A corresponded to
cRNA encoding an N terminal fragment of the polypeptide, while B corresponded to cRNA encoding a fragment of the variable loop between
repeat domains II and III. Probe B encompassed the antigenic peptide (*) used to generate the commercially available antibody used in most
published immunohistochemical studies of Cav1.3 (α1D) expression.
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the GenBank databases to confirm their specificity for the
Cav1.3 (α1D) subunit and to demonstrate no cross homology
with the other calcium channel α1 subunit isomers.
As shown in Figure 2A and Figure 2B, Cav1.3 (α1D)
mRNA expression was detected in the majority of the cells of
the outer nuclear layer of mouse retina using antisense cRNA
corresponding to the Probe A Figure 2A or the Probe B (Fig-
ure 2B) region of the Cav1.3 (α1D) mRNA. Both antisense
cRNA probes also detected Cav1.3 (α1D) mRNA within most,
if not all, cells of the inner nuclear and ganglion cell layers.
We detected no expression of Cav1.3 (α1D) mRNA, however,
when sense strand cRNA probes corresponding to these same
regions of the Cav1.3 (α1D) mRNA were used. These results
were consistent in multiple experiments from multiple ani-
mals (Probe A: 4 animals, 9 experiments; Probe B: 6 animals,
10 experiments).
Specific in situ detection of Cav1.3 (α1D) mRNA in mouse
hippocampus and cerebellum confirms specificity of both in
situ hybridization probe sets:  Because most, if not all, cells
within each lamina of the retina appear to be expressing some
Cav1.3 (α1D) mRNA, the specificity of the probes was called
into question. In order to address this, we performed in situ
hybridization on sections of wild type mouse brain, where the
expression of Cav1.3 (α1D) has been previously reported to
be concentrated in neurons of the hippocampus and cerebel-
lum [12]. As shown in Figure 3A and Figure 3B, we observed
a virtually identical concentrated expression of Cav1.3 (α1D)
within subsets of neurons within the hippocampus and cer-
ebellum using antisense cRNA corresponding to the Probe A
(Figure 3A) or Probe B (Figure 3B) region of Cav1.3 (α1D)
mRNA. We detected no expression of Cav1.3 (α1D) mRNA
in these regions, however, when sense strand cRNA probes
corresponding to these same regions of the Cav1.3 (α1D)
mRNA were used (Figure 3A,B). These results were obtained
in two independent experiments using both Probe sets A and
B on brain tissue from two unrelated mice. The detection of
Cav1.3 (α1D) mRNA within specific groups of neurons of the
brain is in contrast to the more ubiquitous expression profile
in the retina and supports the specificity of the Cav1.3 (α1D)
probes used in this study.
DISCUSSION
 A limitation of the previously reported immunohistochemi-
cal studies of the localization of Cav1.3 (α1D) is the reliance
upon anti-Cav1.3 (α1D) polyclonal antibodies based upon the
original one of Hell et al. [13]. The antigenic sequence uti-
lized to generate these antibodies is a 20 amino acid sequence
corresponding to a unique peptide located within the intracel-
lular loop between repeat domains II and II of the Cav1.3 (α1D)
polypeptide and was derived from the rat brain Cav1.3 (α1D)
polypeptide sequence. As with most peptide antigen-based
antibodies, the anti-Cav1.3 (α1D) antibodies may have limita-
tions to their usefulness, particularly since specificity has not
been proven on tissues from the Cav1.3 (α1D) null animals
generated by Platzer et al. [14]. In order to avoid these com-
plications, we chose to examine mRNA analysis and utilize
two probe sets corresponding to two different regions of the
mRNA sequence encoding two distinct regions of the polypep-
tide.
While Xu et al. previously reported immunolocalization
of Cav1.3 (α1D) protein to rod photoreceptor somata in rat
retinal sections, it could not be ruled out that this staining rep-
resented processes of the Müller cells ensheathing the rod so-
mata [11]. Using an antibody generated against a different re-
gion of the Cav1.3 (α1D) subunit, Morgans et al. detected
immunoreactivity in cone pedicles [8]. The prominent label-
ing of most, if not all, cells in the outer nuclear layer of retinal
sections in the present study confirms the expression of the
Cav1.3 (α1D) calcium channel subunit in rod photoreceptors.
The very small numbers of cones in the mouse retina preclude
us from making any comment regarding the expression of
Cav1.3 (α1D) mRNA in cones or the potential contribution of
Cav1.3 (α1D) within cones to transmission of light signals
derived via rod-cone coupling to second order neurons of the
retina.
The observation of Cav1.3 (α1D) mRNA expression in
rods raises some other interesting possibilities worthy of seri-
ous consideration in interpreting the reported observations from
cacna1f null mice [6] and the nob2 mutant mice with a natu-
rally occurring mutation in cacna1f, the gene encoding Cav1.4
(α1F) [7]. Specifically, it warrants concern that the Cav1.3
(α1D) subunit protein expression level, localization, or func-
tioning might be altered in addition to that of Cav1.4 (α1F).
Cav1.3 (α1D) protein expression, localization, or functioning
may be coupled to Cav1.4 (α1F) expression, localization, or
functioning, and be compromised as a direct result of the Cav1.4
(α1F) mutations and concomitant aberration in rod-bipolar cell
synapse formation.
Along this same vein of thinking, it is interesting that mice
null for the auxiliary b2 subunit of voltage-dependent calcium
channels have a disrupted outer plexiform synaptic layer and
have abnormal ERG b waves. Consistent with the established
role of auxiliary βsubunits in targeting the pore-forming a sub-
units to the plasma membrane [15], the phenotype of the β2
null mice is presumed to be due to the observed inefficiency
in targeting of Cav1.4 (α1F) subunits to the synapses of rod
photoreceptors. In contrast to mice null for the β2 subunit,
mice null for the β1, β3, or β4 subunit do not exhibit histo-
pathological or functional consequences in the retina [16],
suggesting that the β2 auxiliary subunit plays the most promi-
nent role in targeting the pore-forming calcium channel α1
subunits to the membranes of the synapses within the retina.
To date, no data regarding the identity of the auxiliary βsubunit
associated with the Cav1.3 (α1D) subunit in photoreceptors
has been published. Based upon our finding s in the present
study and the evidence from mice null for the calcium chan-
nel β2 subunit, it is highly likely that the auxiliary β2 subunit
associates with Cav1.3 (α1D) in addition to Cav1.4 (α1F) in
rods and that calcium channels containing the Cav1.3 (α1D)
subunit are substantially reduced in the retinas of mice lack-
ing the β2 subunit. To date, no studies of Cav1.3 (α1D) mRNA
nor protein expression levels or localization in cacna1f mu-
tant mice, the β2 null mice, nor post mortem retinae from hu-
mans with CSNB2 have been published. Our findings warrant
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Figure 2. In situ hybridization analysis of Cav1.3 (α1D) mRNA expression in mouse retinal sections confirms expression in most retinal
neurons, including rod photoreceptors.  A: (Probe A) Retinal sections from wild type C57BL/6J mice were hybridized with A antisense and
sense probes. Antisense probe (left panel) detected Cav1.3 (α1D) mRNA in most, if not all, cells of all three nuclear layers. Sense probe (right
panel) did not detect Cav1.3 (α1D) mRNA in any cells of any nuclear layer. IS represents inner segments; OS represents outer segments; ONL
represents outer nuclear layer; INL represents inner nuclear layer; GCL represents ganglion cell layer. B: (Probe B) In situ hybridization
analysis of Cav1.3 (α1D) mRNA expression in mouse retinal sections confirms expression in most retinal neurons, including rod photorecep-
tors. Retinal sections from wild type C57BL/6J mice were hybridized with B antisense and sense probes. Antisense probe (left panel) detected
Cav1.3 (α1D) mRNA in most, if not all, cells of all three nuclear layers. Sense probe (right panel) did not detect Cav1.3 (α1D) mRNA in any
cells of any nuclear layer.
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Figure 3. In situ hybridization analysis of mouse brain sections confirms specificity of Cav1.3 (α1D) cRNA probes.  A: Brain sections from
wild type C57BL/6J mice were hybridized with Probe A antisense and sense probes. Antisense probe (left panels) detected Cav1.3 (α1D)
mRNA specifically in the hippocampus (middle panel) and cerebellum (bottom panel). In the cerebellum, strong labeling was observed in the
large Purkinje neurons (large somas between molecular and granular cell layers, just below asterisks, *, in bottom panels) and in neurons
within the granular layer, but was absent from cells of the molecular layer. Sense probes (right panels) did not detect Cav1.3 (α1D) mRNA in
any cells of the hippocampus (middle panel) or cerebellum (bottom panel). The observation of such region-specific expression of Cav1.3
(α1D) mRNA in the brain supports the specificity of the Cav1.3 (α1D) probes. B: Brain sections from wild type C57BL/6J mice were
hybridized with Probe B antisense and sense probes. Antisense probe (left panels) detected Cav1.3 (α1D) mRNA specifically in the hippocam-
pus (middle panel) and cerebellum (bottom panel). In the cerebellum, strong labeling was observed in the large Purkinje neurons (large somas
between molecular and granular cell layers, just below asterisks, *, in bottom panels) and in neurons within the granular layer, but was absent
from cells of the molecular layer. Sense probes (right panels) did not detect Cav1.3 (α1D) mRNA in any cells of the hippocampus (middle
panel) or cerebellum (bottom panel). The observation of such region-specific expression of Cav1.3 (α1D) mRNA in the brain supports the
specificity of the Cav1.3 (α1D) probes. Figure 3 continues on the next page.
769such studies to make sure these possibilities are not overlooked.
Finally, in addition to abundant expression in rod photo-
receptors, we noted extensive Cav1.3 (α1D) mRNA expres-
sion in most, if not all, neurons within all three nuclear layers
of the mouse retina. This observation is consistent with the
previously published results of Kamphuis et al. [17] using ra-
diolabeled cRNA probes for in situ analysis of rat retinal sec-
tions. The observation of extensive labeling of cells within
the inner nuclear layer is also consistent with previous reports
of immunohistochemical localization of Cav1.3 (α1D) to the
terminals of rat bipolar cells [18] and putative Müller cell pro-
cesses in rat retina [11] and salamander retina [19,20] and
single-cell RT-PCR detection of Cav1.3 (α1D) mRNA expres-
sion in acutely isolated human Müller cells [21] and mouse
AII amacrine cells [22]. Further experiments using combined
in situ hybridization and immunocytochemical analysis of
retina or acutely dissociated cells with cell specific markers
are required for precise demonstration of the expression of
Cav1.3 (α1D) mRNA within specific cell types of the inner
nuclear layer of the retina. Although not uninteresting, the
question of Cav1.3 (α1D) expression in these other cell types
is beyond the scope of this study, which was to investigate the
©2007 Molecular Vision Molecular Vision 2007; 13:764-71 <http://www.molvis.org/molvis/v13/a83/>
Figure 3, continued.
770potential expression of Cav1.3 (α1D) in rod photoreceptors as
a potential explanation for the observed residual photorecep-
tor function in patients with CSNB2. The apparently ubiqui-
tous expression pattern of Cav1.3 (α1D) mRNA we observed
in the mouse retina suggests the potential for a much broader
role for this L-type calcium channel subunit in overall func-
tioning of the normal retina than previously appreciated. We
therefore suggest that lesions in the gene encoding the L-type
calcium channel Cav1.3 (α1D) subunit or other molecules that
interact with or regulate the L-type calcium channel Cav1.3
(α1D) subunit may underlie one or more retinopathies with
currently unidentified molecular etiologies.
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